Procaps Group, S.A. (PROC) News
Filter PROC News Items
PROC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
PROC News Highlights
- For PROC, its 30 day story count is now at 2.
- Over the past 16 days, the trend for PROC's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest PROC News From Around the Web
Below are the latest news stories about PROCAPS GROUP SA that investors may wish to consider to help them evaluate PROC as an investment opportunity.
Procaps Announces Key Changes to the Board of DirectorsInternational Corporate Executive and Attorney Alberto Eguiguren Correa Appointed to Board of Directors MIAMI and BARRANQUILLA, Colombia, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced the election of Alberto Eguiguren Correa to its Board of Directors. Alberto Eguiguren is an accomplished corporate executive and attorney with board experience including over 20 years in g |
Procaps Group Announces Termination of Acquisition Agreement with Grupo SomarCompany to Provide 2023 Value Creation Plan at J.P. Morgan Healthcare ConferenceMIAMI and BARRANQUILLA, Colombia, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the termination of its previously-reported definitive agreement (the “SPA”) to acquire Grupo Somar from the sellers under the SPA. As previously reported, the closing of the acquisition of Grupo Somar |
Procaps to Present at 2023 Annual J.P. Morgan Healthcare ConferenceMIAMI and BARRANQUILLA, Colombia, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced that it will present at the 2023 J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023, at 8:00 am PST. At that time, Procaps will present its 2023 growth plans to investors. Ruben Minski commented “We look forward to updating our investors on our growth plans for 2023. |
Update on Proposed Acquisition of Grupo SomarMIAMI and BARRANQUILLA, Colo., Dec. 22, 2022 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announces an update on its previously reported definitive agreement, dated as of May 16, 2022 (the “SPA”), to acquire Grupo Somar (including Grupo Farmacéutico Somar, S.A.P.I de C.V., Química y Farmacia S.A. de C.V., Gelcaps Exportadora de Mexico S.A. de C.V. and related entities) from the sellers |
Procaps Group Reports Third Quarter and Nine Months 2022 ResultsConstant currency Net Revenues Increased by 15% year-over-year in the 9M22 and by 11% in the 3Q22, signaling a strong demand across our businessesMIAMI and BARRANQUILLA, Colombia, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended September 30, 2022 (“3Q22”) and the nine months ended September 30, 2022 (“9M22”). “Demand remains robu |
Procaps Group to Report Third Quarter and Nine Months of 2022 on November 14, 2022MIAMI and BARRANQUILLA, Colombia, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced that it expects to report its results for the third quarter ended September 30, 2022, after the market closes on Monday, November 14, 2022. The Company expects to host a conference call and webcast at 04 p.m. Eastern time, on November 16, 2022.To access the call, please use the following information: Date:We |
Procaps Announces ESG Commitments and Initiatives with Inaugural ReportMIAMI and BARRANQUILLA, Colombia, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced the completion of its inaugural 2021 ESG Annual Report, a comprehensive overview of environmental, social and governance metrics and corresponding strategies and initiatives for ESG priorities. Procaps commitments and initiatives include advancing a healthy, climate-resilient future, social responsibil |
Procaps Group to Participate in the BTG Pactual LatAm CEO ConferenceMIAMI and BARRANQUILLA, Colombia, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced it will participate in the BTG Pactual LatAm CEO Conference being held at the InterContinental NY Barclays Hotel October 11-13, 2022. Procaps Group Chief Executive Officer Rubén Minski, Chief Financial Officer Patricio Vargas, and Investor Relations Director Melissa Angelini will conduct in-person one- |
Procaps Group Reports Second Quarter and First Half 2022 ResultsNet Revenues Increased 14% year-over-year in the Second Quarter, with Adjusted EBITDA Margin of 24%Constant currency Net Revenues Increased by 18% year-over-year in the First Half, signaling a strong demand across our businesses MIAMI and BARRANQUILLA, Colombia, Aug. 30, 2022 (GLOBE NEWSWIRE) -- Procaps Group S.A. (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today announced its financial results for the three months ended June 30, 2022 (“2Q22 |
Calculating The Intrinsic Value Of Procaps Group S.A. (NASDAQ:PROC)Today we will run through one way of estimating the intrinsic value of Procaps Group S.A. ( NASDAQ:PROC ) by taking the... |